Sonnet BioTherapeutics
SONN
SONN
9 hedge funds and large institutions have $1.45M invested in Sonnet BioTherapeutics in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
5
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Hudson Bay Capital Management
Stamford,
Connecticut
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $582K | 222,222 | – | – |
|
|
TDC
2
Thompson Davis & Co
Richmond,
Virginia
| $514K | 196,182 | +16,750 | +9% |
|
|
BIT
3
BlackRock Institutional Trust
San Francisco,
California
| $149K | 56,692 | – | – |
|
|
CDH
4
Charles D. Hyman
| $116K | 44,444 | – | – |
|
5
Bank of America
Charlotte,
North Carolina
| $56K | 21,429 | +1 | +0% |
|
|
WA
6
WFG Advisors
Dallas,
Texas
| $22K | 8,332 | +8,332 | New |
|
|
U
7
UBS
Zurich,
Switzerland
| $8K | 3,128 | +1,128 | +56% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2K | 791 | +391 | +98% |
|
|
9
Hudson Bay Capital Management
Stamford,
Connecticut
| – | – | -10,000 | Closed |
|
10
Morgan Stanley
New York
| $0 | 11 | +2 | +22% |
|